AAAAAA
Results:
1-8
|
Results: 8
Authors:
Devereux, HL
Burke, A
Lee, CA
Johnson, MA
Citation: Hl. Devereux et al., In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution, J MED VIROL, 66(1), 2002, pp. 8-12
Authors:
Devereux, HL
Emery, VC
Johnson, MA
Loveday, C
Citation: Hl. Devereux et al., Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations, J MED VIROL, 65(2), 2001, pp. 218-224
Authors:
Devereux, HL
Loveday, C
Youle, M
Sabin, CA
Burke, A
Johnson, M
Citation: Hl. Devereux et al., Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients, AIDS RES H, 16(11), 2000, pp. 1025-1030
Authors:
Sabin, CA
Devereux, HL
Clewley, G
Emery, VC
Phillips, AN
Loveday, C
Lee, CA
Griffiths, PD
Citation: Ca. Sabin et al., Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNAlevels in individuals with hemophilia, J INFEC DIS, 181(5), 2000, pp. 1800-1803
Authors:
Devereux, HL
Loveday, C
Youle, M
Sabin, CA
Burke, A
Johnson, MA
Citation: Hl. Devereux et al., Reduction in human immunodeficiency virus type 1 mutations associated withdrug resistance after initiating new therapeutic regimens in pretreated patients, J INFEC DIS, 181(5), 2000, pp. 1804-1807
Authors:
Pasi, KJ
Sabin, CA
Jenkins, PV
Devereux, HL
Ononye, C
Lee, CA
Citation: Kj. Pasi et al., The effects of the 32-bp CCR-5 deletion on HIV transmission and HIV disease progression in individuals with haemophilia, BR J HAEM, 111(1), 2000, pp. 136-142
Authors:
Devereux, HL
Youle, M
Johnson, MA
Loveday, C
Citation: Hl. Devereux et al., Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy, AIDS, 13(18), 1999, pp. F123-F127
Authors:
Devereux, HL
Citation: Hl. Devereux, Automated DNA sequencing, METH MOL M, 31, 1999, pp. 55-61
Risultati:
1-8
|